Determination of Cell Survival or Death

  • Alexander E. Kabakov
  • Vladimir A. Kudryavtsev
  • Vladimir L. GabaiEmail author
Part of the Methods in Molecular Biology book series (MIMB, volume 787)


Cell death (in particular, apoptosis and necrosis) is accompanied by appearance of certain hallmarks that are manifested as specific alterations in cellular membranes, cytoplasm, nucleus and mitochondria. Some of those hallmarks are easily detectable in situ and, therefore, they can be applied for the assessment of dying or dead cells. In turn, there are also signs of viable cells that include a set of features, such as normal functioning of their membranes and organelles, ability to proliferate, etc. The present chapter provides descriptions of several convenient methods for quantitative determination of dead (apoptotic and necrotic) cells and also methods for determination of survived and viable cells. Here, we describe in details the methods of annexin V/propidium iodide (PI) staining, TUNEL assay, Hoechst/PI staining, MTS tetrazolium assay, and colony formation assay, with the principles, advantages, and drawbacks of each technique.

Key words

Apoptosis Necrosis Annexin V TUNEL Colony formation assay Tetrazolium assay 


  1. 1.
    Xanthoudakis, S., and Nicholson, D.W. (2000) Heat-shock proteins as death determinants. Nature Cell Biol 2, E163-E165.Google Scholar
  2. 2.
    Beer, H.M. (2005) Death versus survival: functional interaction between the apoptotic and stress-inducible heat shock protein pathways. J Clin Invest 115, 2633–9.Google Scholar
  3. 3.
    Arya, R., Mallik, M., and Lakhotia, S.C. (2007) Heat shock genes – integrating cell survival and death. J Biosci 32, 595–610.Google Scholar
  4. 4.
    Ciocca, D.R., and Calderwood, S.K. (2005) Heat shock proteins in cancer: diagnostic, prognostic, predictive, and treatment implications. Cell Stress Chaperones 10, 86–103.Google Scholar
  5. 5.
    Raynal, P., and Pollard, H.B. (1994) Annexins: the problem of assessing the biological role for a gene family of multifunctional calcium- and phospholipids-binding proteins. Biochim Biophys Acta 1197, 63–93.Google Scholar
  6. 6.
    Martin, S.J., Reutelingsperger, C.P., McGahon, A.J., Rader, J.A., van Schie, R.C., Laface, D.M., and Green, D.R. (1995) Early redistribution of plasma membrane phosphatidylserine is a general feature of apoptosis regardless of the initiating stimulus: inhibition by overexpression of bcl-2 and Abl. J Exp Med 182, 1545–1556.Google Scholar
  7. 7.
    Vermes, I., Haanen, C., Steffens-Nakken, H., and Reutelingsperger, C. (1995) A novel assay for apoptosis. Flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled Annexin V. J Immunol Meth 184, 39–51.Google Scholar
  8. 8.
    Hwang, M., Moretti, L., and Lu, B. (2009) Hsp90 inhibitors: multi-target antitumor effects and novel combinatorial therapeutic approaches in cancer therapy. Curr Med Chem 16, 3081–3092.Google Scholar
  9. 9.
    Kabakov, A.E. (2009) Geldanamycin derivatives as promising anticancer drugs: therapy via Hsp90 inhibition. In: Anticancer Drugs: Design, Delivery and Pharmacology (Spencer, P., and Holt, W., eds.), Nova Science Publishers, New York, pp. 87–113.Google Scholar
  10. 10.
    Samejima, K., and Earnshaw, W.C. (2005) Trashing the genome: The role of nucleases during apoptosis. Nat Rev Mol Cell Biol 6, 677–688.Google Scholar
  11. 11.
    Gavrieli, Y., Sherman, Y., and Ben-Sasson, S.A. (1992) Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol 119, 493–501.Google Scholar
  12. 12.
    Rossi, A., Ciafre, S., Balsamo, M., Pierimarchi, P., and Santoro, M.G. (2006) Targeting the heat shock factor 1 by RNA interference: A potent tool to enhance hyperthermochemotherapy efficacy in cervical cancer. Cancer Res 66, 7678–7685.Google Scholar
  13. 13.
    Westerheide, S.D., Kawahara, T.L.A., Orton, K., and Morimoto, R.I. (2007) Triptolide, an inhibitor of the human heat shock response that enhances stress-induced cell death. J Biol Chem 281, 9616–9622.Google Scholar
  14. 14.
    Roninson, I.B., Broude, E.V., and Chang, B.-D. (2001) If not apoptosis, then what? Treatment-induced senescence and mitotic catastrophe in tumor cells. Drug Resistance Updates 4, 303–313.Google Scholar
  15. 15.
    Roninson, I.B. (2003) Tumor Cell Senescence in Cancer Treatment. Cancer Res 63, 2705–2715.Google Scholar
  16. 16.
    Schmitt, C.A. (2007) Cellular senescence and cancer treatment. Biochim Biophys Acta (BBA) - Reviews on Cancer 1775, 5–20.Google Scholar
  17. 17.
    Yaglom, J.A., Gabai, V.L. and Sherman, M.Y. (2007) High Levels of Heat Shock Protein Hsp72 in Cancer Cells Suppress Default Senescence Pathways. Cancer Res 67, 2373–2381.Google Scholar
  18. 18.
    Gabai, V.L., Sherman, M.Y., and Yaglom, JA. (2010). Hsp72 depletion suppresses gammaH2AX activation by genotoxic stresses via p53/p21 signaling. Oncogene 29, 1952–1962.Google Scholar
  19. 19.
    Casciola-Rosen, L., Rosen, A., Petri, M, and Schlissel, M. (1996) Surface blebs on apoptotic cells are sites of enhanced procoagulant activity: Implications for coagulation events and antigenic spread in systemic lupus erythematosus. Proc Natl Acad Sci USA 93, 1624–9.Google Scholar
  20. 20.
    van Engeland, M., Ramaekers, F.C., Schutte, B., and Reutelingsperger, C.P. (1996) A novel assay to measure loss of plasma membrane asymmetry during apoptosis of adherent cells in culture. Cytometry 24, 131–9.Google Scholar
  21. 21.
    Lauber, K., Blumenthal, S.G., Waibel, M., and Wesselborg, S. (2004) Clearance of apoptotic cells: getting rid of the corpses. Mol Cell 14, 277–287.Google Scholar

Copyright information

© Springer Science+Business Media, LLC 2011

Authors and Affiliations

  • Alexander E. Kabakov
    • 1
  • Vladimir A. Kudryavtsev
    • 1
  • Vladimir L. Gabai
    • 2
    Email author
  1. 1.Department of Radiation BiochemistryMedical Radiology Research CenterObninskRussia
  2. 2.Department of BiochemistryBoston University Medical SchoolBostonUSA

Personalised recommendations